FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4288077275> ?p ?o ?g. }

• W4288077275 endingPage "747" @default.
• W4288077275 startingPage "740" @default.
• W4288077275 abstract "Objective: The authors examined the impact of COVID-19-related policies reducing barriers to telehealth delivery of buprenorphine treatment for opioid use disorder (OUD) on buprenorphine treatment across different modalities (telephone, video, and in-person visits). Methods: This was a national retrospective cohort study with interrupted time-series analyses to examine the impact of policy changes in March 2020 on buprenorphine treatment for OUD in the Veterans Health Administration, during the year before the start of the COVID-19 pandemic (March 2019 to February 2020) and during the first year of the pandemic (March 2020 to February 2021). The authors also examined trends in the use of telephone, video, and in-person visits for buprenorphine treatment and compared patient demographic characteristics and retention in buprenorphine treatment across the two periods. Results: The number of patients receiving buprenorphine increased from 13,415 in March 2019 to 15,339 in February 2021. By February 2021, telephone visits were used by the most patients (50.2%; 4,456 visits), followed by video visits (32.4%; 2,870 visits) and in-person visits (17.4%; 1,544 visits). During the pre-pandemic period, the number of patients receiving buprenorphine increased significantly by 103 patients per month. After the COVID-19 policy changes, there was an immediate increase of 265 patients in the first month, and the number continued to increase significantly, at a rate of 47 patients per month. The demographic characteristics of patients receiving buprenorphine during the pandemic period were similar to those during the pre-pandemic period, but the proportion of patients reaching 90-day retention on buprenorphine treatment decreased significantly from 49.6% to 47.7%, while days on buprenorphine increased significantly from 203.8 to 208.7. Conclusions: The number of patients receiving buprenorphine continued to increase after the COVID-19 policy changes, but the delivery of care shifted to telehealth visits, suggesting that any reversal of COVID-19 policies must be carefully considered." @default.
• W4288077275 created "2022-07-28" @default.
• W4288077275 creator A5003547177 @default.
• W4288077275 creator A5028538148 @default.
• W4288077275 creator A5072644098 @default.
• W4288077275 creator A5089202951 @default.
• W4288077275 date "2022-10-01" @default.
• W4288077275 modified "2023-10-17" @default.
• W4288077275 title "Impact of COVID-19 Telehealth Policy Changes on Buprenorphine Treatment for Opioid Use Disorder" @default.
• W4288077275 cites W185237278 @default.
• W4288077275 cites W2110132657 @default.
• W4288077275 cites W2199943438 @default.
• W4288077275 cites W2575251737 @default.
• W4288077275 cites W2736062301 @default.
• W4288077275 cites W2795213505 @default.
• W4288077275 cites W2808907017 @default.
• W4288077275 cites W2912693422 @default.
• W4288077275 cites W2944661632 @default.
• W4288077275 cites W3007256858 @default.
• W4288077275 cites W3039751098 @default.
• W4288077275 cites W3080598282 @default.
• W4288077275 cites W3081101017 @default.
• W4288077275 cites W3086642606 @default.
• W4288077275 cites W3094621110 @default.
• W4288077275 cites W3106631792 @default.
• W4288077275 cites W3112668148 @default.
• W4288077275 cites W3115660820 @default.
• W4288077275 cites W3118888943 @default.
• W4288077275 cites W3120867475 @default.
• W4288077275 cites W3121835404 @default.
• W4288077275 cites W3128275005 @default.
• W4288077275 cites W3168477510 @default.
• W4288077275 cites W3171657343 @default.
• W4288077275 cites W3179353766 @default.
• W4288077275 cites W3193913968 @default.
• W4288077275 cites W3201252843 @default.
• W4288077275 cites W3207661914 @default.
• W4288077275 doi "https://doi.org/10.1176/appi.ajp.21111141" @default.
• W4288077275 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35899380" @default.
• W4288077275 hasPublicationYear "2022" @default.
• W4288077275 type Work @default.
• W4288077275 citedByCount "16" @default.
• W4288077275 countsByYear W42880772752022 @default.
• W4288077275 countsByYear W42880772752023 @default.
• W4288077275 crossrefType "journal-article" @default.
• W4288077275 hasAuthorship W4288077275A5003547177 @default.
• W4288077275 hasAuthorship W4288077275A5028538148 @default.
• W4288077275 hasAuthorship W4288077275A5072644098 @default.
• W4288077275 hasAuthorship W4288077275A5089202951 @default.
• W4288077275 hasConcept C126322002 @default.
• W4288077275 hasConcept C160735492 @default.
• W4288077275 hasConcept C162324750 @default.
• W4288077275 hasConcept C167135981 @default.
• W4288077275 hasConcept C170493617 @default.
• W4288077275 hasConcept C194828623 @default.
• W4288077275 hasConcept C2778949969 @default.
• W4288077275 hasConcept C2779134260 @default.
• W4288077275 hasConcept C2779418921 @default.
• W4288077275 hasConcept C2779891985 @default.
• W4288077275 hasConcept C2781050511 @default.
• W4288077275 hasConcept C2781063702 @default.
• W4288077275 hasConcept C2909451232 @default.
• W4288077275 hasConcept C3008058167 @default.
• W4288077275 hasConcept C50522688 @default.
• W4288077275 hasConcept C524204448 @default.
• W4288077275 hasConcept C71924100 @default.
• W4288077275 hasConcept C72563966 @default.
• W4288077275 hasConcept C89623803 @default.
• W4288077275 hasConceptScore W4288077275C126322002 @default.
• W4288077275 hasConceptScore W4288077275C160735492 @default.
• W4288077275 hasConceptScore W4288077275C162324750 @default.
• W4288077275 hasConceptScore W4288077275C167135981 @default.
• W4288077275 hasConceptScore W4288077275C170493617 @default.
• W4288077275 hasConceptScore W4288077275C194828623 @default.
• W4288077275 hasConceptScore W4288077275C2778949969 @default.
• W4288077275 hasConceptScore W4288077275C2779134260 @default.
• W4288077275 hasConceptScore W4288077275C2779418921 @default.
• W4288077275 hasConceptScore W4288077275C2779891985 @default.
• W4288077275 hasConceptScore W4288077275C2781050511 @default.
• W4288077275 hasConceptScore W4288077275C2781063702 @default.
• W4288077275 hasConceptScore W4288077275C2909451232 @default.
• W4288077275 hasConceptScore W4288077275C3008058167 @default.
• W4288077275 hasConceptScore W4288077275C50522688 @default.
• W4288077275 hasConceptScore W4288077275C524204448 @default.
• W4288077275 hasConceptScore W4288077275C71924100 @default.
• W4288077275 hasConceptScore W4288077275C72563966 @default.
• W4288077275 hasConceptScore W4288077275C89623803 @default.
• W4288077275 hasIssue "10" @default.
• W4288077275 hasLocation W42880772751 @default.
• W4288077275 hasLocation W42880772752 @default.
• W4288077275 hasOpenAccess W4288077275 @default.
• W4288077275 hasPrimaryLocation W42880772751 @default.
• W4288077275 hasRelatedWork W2012038271 @default.
• W4288077275 hasRelatedWork W3091800028 @default.
• W4288077275 hasRelatedWork W3125328366 @default.
• W4288077275 hasRelatedWork W3129170610 @default.
• W4288077275 hasRelatedWork W3160430790 @default.
• W4288077275 hasRelatedWork W3174344100 @default.

• next